Vancomycin DR. Eberth
Capsules for oral use
Vancomycin DR. Eberth
| dosage/strength | dosage form | pack size | pharmaceutical registration number | SmPC | |
|---|---|---|---|---|---|
| 125 mg | capsules for oral use | 12 capsules | N1 | 11284041 |  |
| capsules for oral use | 28 capsules | N2 | 11284058 | ||
| 250 mg | capsules for oral use | 4 capsules | 11293761 | | |
| capsules for oral use | 12 capsules | N1 | 11293778 | ||
| capsules for oral use | 28 capsules | N2 | 11293784 | ||
| capsules for oral use | 30 capsules | N2 | 11293790 |
Active substance:
Vancomycin hydrochloride
Pharmacotherapeutic group:
Intestinal anti-infectives, antibiotics,
ATC code: A07AA09
Mechanismen of action:
Vancomycin is a tricyclic glycopeptide antibiotic that inhibits the synthesis of the cell wall in sensitive bacteria by binding with high affinity to the D-alanyl-D-alanine terminus of cell wall precursor units. The drug is bactericidal for dividing microorganisms. In addition, it impairs the permeability of the bacterial cell membrane and RNA synthesis.
Therapeutic indications
Vancomycin Dr. Eberth capsules are indicated in patients 12 years and older for the treatment of Clostridioides difficile infection (CDI).